Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

VALIANTLAB ☆ NSE also on BSE

VALIANT LABORATORIES LTD · code 19220 · INE0JWS01017 · Pharma & Healthcare · series BE · Daily price history

94.91 -1.93 (-1.99%) close on 20 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
47

ISA Signal Score: Neutral

Hold or watch: no clear edge. Based on prices to 2026-11-20. Confidence 100%.

Trend60
Momentum33
52-week range49
Volume24
Risk57
Fundamentals48

Working for it

  • Price is above its 200-day average (long-term uptrend)
  • 50-day average is above the 200-day average
  • 50-day average is rising
  • Revenue grew 78% year on year

Working against it

  • Price is below its 20-day average
  • Price is below its 50-day average
  • RSI 23: weak (oversold, but not turning yet)
  • More volume on down days than up days (distribution)
  • Low ROE (0%)

Red flags

  • Thinly traded: average daily turnover is low, so entering or exiting can be hard

Measured reference levels (not forecasts): 20-day low 94.91, 52-week high 140.75, typical daily move 2.41, two typical moves below price 90.10.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityNot knownNeeds the yearly results. They load from NSE on their own for NSE stocks.
GrowthFastSales 14.2% a year over 2 years
ValuationNo earningsP/E cannot be worked out while the company makes a loss.
MomentumStrongAbove its 200-day average, beat NIFTY 50 by 24.8 points
RiskHighSwings 53% a year, fell up to 34% from a peak, beta 0.64

Smart Investor Tips: VALIANTLAB

Caution Warranted (Trend or Balance-Sheet Headwinds)

Actionable Insights & Positives

  • Pullback within a long-term uptrend: holding above the 200-day average (Rs 81.86) while digesting gains below the 50-day average (Rs 120.41).
  • RSI is oversold at 23 (< 30). Watch for a bullish reversal candle (hammer or engulfing) with volume confirmation.
  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

Risk Checks & Things to Verify

  • Reported a net loss in FY26. Turnaround stories carry higher execution risk.

NSE MCP Live & 5-Year Check No API Key

Connects directly to NSE's official Model Context Protocol servers (cm-market for live 1–3 min delayed quote & nse-bhavcopy for 52W range, 20/50/200 DMA, 20-day volume surge, and corporate actions), and syncs missing sessions into your database.

Algorithmic Momentum Prediction & Optimal Entry PriceWEAK / REDUCE ON BOUNCES (Score 26/100)

Weak trend, debt overhang, or distribution. Avoid fresh buying until price reclaims 50-DMA (Rs 120.41). If already held, protect capital if it breaks below Rs 77.48 or trim near resistance Rs 130.88.

Optimal Support areaTranche 1 (50%)Tranche 2 (50%)Risk level / ReviewLevel 1 (Swing)Level 2 (Breakout)Risk : Reward
Rs 91.53 – Rs 94.91
Ideal ~Rs 93.22
Rs 94.91 Rs 91.53 Rs 77.48
ATR 2.5%
Rs 130.88 Rs 141.38 1 : 2.4
RSI 0 · Vol 0.60x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 6M change +26.3% · high 141.38 · low 58.08 · max drawdown -32.6%

Live Candlestick & TradingView Chart (VALIANTLAB)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures results FY26, price 20 Nov

P/E-loss making
P/B-price / book value
EPSRs -0.55earnings per share
Dividend yield-from saved dividend events
Debt to equity-borrowings / equity
Sales growth14.2%a year over 2 years
Profit growth-yearly, needs 2+ years
Operating margin2.7%net margin -1.4%

From the official NSE results filings, consolidated. P/E uses the last full year's EPS. See all years.

Company Debt, Borrowings & Cash Flow Health (Official FY26 Consolidated Filing)

Auto-extracted from official NSE/BSE XBRL Balance Sheet & Cash Flow statements (Rs Crore).

High Debt / Cash Flow Caution · Score 40/100
Total Debt / Loans - Long + short-term loans
Cash & Bank Balances - Liquid cash & equivalents
Net Debt (Loans − Cash) - Net loan obligation
Debt to Equity & Interest Cover - Interest cover: 1.4x EBIT
Operating Cash Flow (OCF) - Cash generated from operations
Free Cash Flow (FCF) - OCF minus Capex
  • Interest coverage stress (1.4x) - operating profit barely covers loan interest.

About VALIANT LABORATORIES

No company description saved yet. Use Profile below to read about this company.

Listed on BSE NSE

Market capRs 412 CrMicro cap · 4.35 Cr shares
First listed06 Oct 2023BSE not available · NSE 06 Oct 2023
Face valueRs 10
Book valueRs 54.51Price is 1.7x book value
ROE0.1%weak, below 8%
ROCE-0.2%losing money on capital

NSE results filing: shares, book value, ROE, ROCE · NSE: listing date, face value · ratios as of FY2024

Profile completeness6 of 8Missing: description, industry · ratios as of FY2024

Checked: NSE results 22 Nov 2026.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 74.94% 0.00 pp, public 25.06%, as on 30 Sep 2026. Holder names and history

Day range94.91 to 94.91Open 94.91
52-week high141.38 -32.9% from high (19 Oct 2026)
52-week low49.51 +91.7% from low (04 Mar 2026)
Volume18,314 1.0x the 20-day average
RSI (14)23 oversold
Volatility (30d)40.8%annualised
49.51
141.38

Returns

1W-9.6%
1M-29.0%
3M-0.9%
6M+23.5%
1Y+23.3%
YTD+35.6%
3Y a year-19.9%

Against the NIFTY 50

PeriodVALIANTLABNIFTY 50Difference
1M-29.0%+13.1% -42.1 pts
3M-0.9%+6.4% -7.3 pts
6M+23.5%+8.8% +14.7 pts
1Y+23.3%-1.5% +24.8 pts

Risk over the past year

Volatility53%high
Deepest fall-33.9%from a peak
Beta0.64moves less than the index
Best day+14.2%09 Feb 2026
Worst day-7.7%23 Mar 2026
Up days44%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition

Institutional balance-sheet quality, earnings-to-cash conversion, and ROE driver breakdown from official XBRL filings.

Piotroski F-Score: 1 / 9 · Weak / Watch Balance Sheet
⚠ Positive Net Profit (PAT > 0) Rs -3.28 Cr
⚠ Positive Operating Cash Flow (OCF > 0) N/A
⚠ High Cash Conversion (OCF >= 85% of PAT) N/A
⚠ Improving Return on Assets (ROA YoY) N/A
⚠ Conservative / Decreasing Debt-to-Equity Bank/Low
⚠ Healthy Balance Sheet Asset Coverage Verified
⚠ Institutional Return on Equity (ROE >= 14%) N/A
✓ Stable / Expanding Profit Margin YoY -1.4% vs -3.5%
⚠ Asset Turnover Efficiency (Sales / Assets) N/A

Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales / Revenue 35.257.846.846.252.592.0115117
Sales QoQ % +64.0%+64.0%-19.0%-1.3%+13.5%+75.3%+25.3%+1.3%
Operating Profit 0.623.822.390.08-0.894.8129.35.18
Operating Margin (OPM %) 1.8%6.6%5.1%0.2%-1.7%5.2%25.4%4.4%
Net Profit (PAT) 1.600.701.820.20-7.061.7621.10.41
Profit QoQ % +126.8%-56.3%+160.0%-89.0%-3630.0%+124.9%+1098.9%-98.1%
Profit YoY % +145.7%+157.4%+280.2%+103.3%-541.3%+151.4%+1059.3%+105.0%
Net Margin % 4.5%1.2%3.9%0.4%-13.5%1.9%18.3%0.4%

Sales and profit Rs crore, consolidated

Sales growth+14.2%a year, 2Y
Profit growth-a year, 2Y
EPS growth-a year, 2Y
Avg ROE-0.9%2 years

Profit and loss

Rs croreFY24FY25FY26
Sales182133237
Sales growth--26.7%+78.0%
Operating profit-8.40-4.686.39
Operating margin-4.6%-3.5%2.7%
Other income9.682.462.33
Interest0.080.171.90
Depreciation1.972.046.04
Profit before tax-0.77-4.430.78
Tax rate---523.1%
Net profit0.32-4.69-3.28
Profit growth--1565.6%-
Net margin0.2%-3.5%-1.4%
EPS (Rs)0.13-1.10-0.55

Balance sheet

Rs croreFY24FY25FY26
Equity (net worth)237--
Borrowings76.1--
Cash106--
Total assets343--
Debt to equity0.32x--

Debt, Loans, Cash Flow & Working Capital

Rs croreFY24FY25FY26
Operating Cash Flow (OCF)1.89--
Capital Expenditure (Capex)45.9--
Free Cash Flow (FCF = OCF - Capex)-44.0--
OCF / Net Profit Conversion5.91x--
Total Borrowings / Loans76.1--
Cash & Bank Balances106--
Trade Receivables (Cr)45.7--
Receivable Days91.68x--
Inventories (Cr)10.0--
Inventory Days20.09x--

Returns on capital

Rs croreFY24FY25FY26
ROE0.1%-2.0%-
ROCE-0.2%-1.4%-
Interest cover-8.63x-25.06x1.41x

Read from the official annual results filed with NSE (XBRL), consolidated figures. ROE uses average equity of the year and the year before when both are saved, ROCE uses profit before interest and tax over total assets less current liabilities. EPS is per today's share. Check the annual report before investing.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
SUNPHARMASUN PHARMACEUTICAL IND L 1,884.90 -0.8% - 452,244 39.4 - 15.0% 19.7%
TORNTPHARMTORRENT PHARMACEUTICALS L 4,689.50 +1.7% - 158,505 74.2 - 24.2% 15.3%
LAURUSLABSLAURUS LABS LIMITED 2,294.60 -0.5% - 123,667 139.4 23.3 16.8% 13.1%
ZYDUSLIFEZYDUS LIFESCIENCES LTD 1,200.00 -0.2% - 120,720 24.0 4.5 18.9% 18.9%
MANKINDMANKIND PHARMA LIMITED 2,665.00 +1.4% - 106,757 55.8 11.4 20.4% 18.5%
MAXHEALTHMAX HEALTHCARE INS LTD 1,081.00 +3.9% - 105,063 72.9 9.8 13.4% 17.2%
LUPINLUPIN LIMITED 2,014.00 +0.8% - 91,778 17.3 - 13.4% 19.2%
GLENMARKGLENMARK PHARMACEUTICALS 2,648.00 +1.5% - 74,724 - 9.5 -19.1% -12.7%
FORTISFORTIS HEALTHCARE LTD 825.00 +1.9% - 62,284 59.8 - 7.8% 11.7%
GLANDGLAND PHARMA LIMITED 3,331.90 +1.2% - 54,880 53.4 - 8.9% 16.0%
IPCALABIPCA LABORATORIES LTD 1,843.80 -0.9% - 46,777 41.0 5.8 14.7% 12.3%
GLAXOGLAXOSMITHKLINE PHARMA LT 2,727.60 +0.5% - 46,208 78.3 26.0 33.2% 17.1%
Sector median- 55.86.713.6%

The 12 largest of 80 stocks in this sector on NSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 20 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is below its 50-day average 20-day average is below the 50-day (short-term downtrend) Price is above its 200-day average (long-term uptrend) RSI 23: oversold zone, a bounce is more likely

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the lower half of its 1-year range and is lower than it was on 24% of days in the past year.

Support (prices below today's)

60-day low91.53-3.6%
200-day average81.86-13.7%
52-week low49.51-47.8%

Resistance (prices above today's)

50-day average120.41+26.9%
20-day high130.88+37.9%
60-day high141.38+49.0%
52-week high141.38+49.0%

Zones buyers often watch

Lower quarter of the 1-year range 49.51 to 72.48 Historically the cheapest part of the past year.
Pullback of 10% to 20% from the high 113.10 to 127.24 A common area for dips inside an uptrend.
Around the 200-day average 79.40 to 84.32 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -33.9%. Currently -32.6% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average114.60 Price is 17.2% below
50-day average120.41 Price is 21.2% below
200-day average81.86 Price is 15.9% above
RSI (14)23Oversold zone
MACD (12, 26, 9)-6.71Below its signal line (momentum fading)
Volatility (30d)40.8%Medium yearly swings

Support and resistance

R294.91
R194.91
Pivot94.91
S194.91
S294.91

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-20 94.91 94.91 94.91 94.91 -1.99% 18,314
2026-11-19 96.84 96.84 96.84 96.84 -1.99% 3,348
2026-11-18 98.81 98.81 98.81 98.81 -1.99% 4,150
2026-11-17 100.82 100.82 100.82 100.82 -1.99% 2,203
2026-11-16 102.87 102.87 102.87 102.87 -1.99% 5,561
2026-11-13 104.96 104.96 104.96 104.96 -2.00% 2,665
2026-11-12 107.10 107.10 107.10 107.10 -1.99% 3,116
2026-11-11 109.28 109.28 109.28 109.28 -2.00% 3,590
2026-11-09 111.51 111.51 111.51 111.51 -2.00% 4,545
2026-11-06 116.10 116.10 116.10 116.10 -1.99% 3,573
2026-11-05 118.46 118.46 118.46 118.46 -1.99% 5,041
2026-11-04 120.87 120.87 120.87 120.87 -1.99% 10,754
2026-11-03 123.33 123.33 123.33 123.33 -1.99% 9,901
2026-11-02 125.85 128.60 125.84 125.84 -1.99% 77,172
2026-10-30 130.88 130.88 128.33 128.40 +0.05% 11,688
2026-10-29 125.00 128.33 125.00 128.33 +1.99% 37,932
2026-10-28 120.91 125.82 120.90 125.82 +1.99% 86,797
2026-10-27 123.36 123.36 123.36 123.36 -1.99% 6,312
2026-10-26 125.87 125.87 125.87 125.87 -1.99% 58,282
2026-10-23 128.43 128.43 128.43 128.43 -2.00% 9,957
2026-10-22 131.05 131.05 131.05 131.05 -2.00% 11,514
2026-10-21 138.40 138.40 133.72 133.72 -4.99% 106,424
2026-10-19 141.38 141.38 132.00 140.75 +4.53% 196,125
2026-10-16 125.25 134.65 125.25 134.65 +5.00% 104,608
2026-10-15 122.44 128.56 120.00 128.24 +4.74% 108,638
2026-10-14 122.90 123.60 118.00 122.44 +0.30% 22,087
2026-10-13 122.35 123.50 119.13 122.07 +2.93% 47,695
2026-10-12 122.00 124.50 117.50 118.59 -1.01% 35,830
2026-10-09 119.00 121.00 113.00 119.80 +2.10% 57,995
2026-10-08 124.79 125.00 117.05 117.34 -4.76% 67,041
2026-10-07 126.00 126.00 120.65 123.21 -0.93% 45,361
2026-10-06 124.00 127.99 124.00 124.37 -0.17% 73,168
2026-10-05 128.85 128.85 119.05 124.58 -0.40% 70,647
2026-10-01 128.70 130.00 120.10 125.08 -0.91% 163,055
2026-09-30 122.76 127.88 121.25 126.23 +3.31% 92,323
2026-09-29 121.85 122.80 115.00 122.19 +2.71% 52,840
2026-09-28 126.00 126.00 118.63 118.97 -4.72% 89,589
2026-09-25 123.15 126.50 119.52 124.87 +1.40% 62,693
2026-09-24 121.24 125.99 117.30 123.15 +1.58% 77,365
2026-09-23 128.65 129.00 120.24 121.24 -4.20% 100,822
2026-09-22 127.10 132.25 125.88 126.56 -0.41% 65,482
2026-09-21 122.05 129.30 118.05 127.08 +3.10% 126,186
2026-09-18 127.15 128.88 121.00 123.26 +0.42% 155,553
2026-09-17 111.25 122.75 111.25 122.75 +5.00% 67,876
2026-09-16 117.00 119.82 116.50 116.91 -4.66% 111,457
2026-09-15 125.01 129.50 121.52 122.63 -4.13% 104,961
2026-09-11 118.56 129.90 118.56 127.91 +2.49% 234,978
2026-09-10 123.20 125.82 121.00 124.80 +4.15% 286,847
2026-09-09 116.60 119.83 115.27 119.83 +4.99% 118,328
2026-09-08 109.80 114.13 106.00 114.13 +5.00% 198,717
2026-09-07 110.90 110.90 104.10 108.70 +2.58% 171,865
2026-09-04 105.97 105.97 105.00 105.97 +4.99% 71,202
2026-09-03 99.50 100.93 99.00 100.93 +4.99% 44,968
2026-09-02 92.58 96.13 92.58 96.13 +4.99% 296,583
2026-09-01 96.34 99.28 91.53 91.56 -4.96% 97,464
2026-08-31 102.30 102.30 94.67 96.34 -3.32% 248,647
2026-08-28 108.75 108.75 99.65 99.65 -5.00% 94,454
2026-08-27 107.87 109.20 103.00 104.89 -2.76% 363,930
2026-08-26 106.99 110.70 103.32 107.87 +2.27% 385,876
2026-08-25 105.50 105.54 98.50 105.48 +4.93% 899,019
2026-08-24 97.90 100.52 97.21 100.52 +4.99% 174,713
2026-08-21 93.90 96.24 90.94 95.74 +4.45% 360,356
2026-08-20 94.80 95.00 88.40 91.66 -0.33% 295,912
2026-08-19 95.10 95.10 86.31 91.96 +1.22% 523,142
2026-08-18 90.85 90.85 88.27 90.85 +4.99% 405,249
2026-08-17 86.53 86.53 86.53 86.53 +5.00% 19,553
2026-08-14 82.41 82.41 82.41 82.41 +4.99% 41,064
2026-08-13 78.49 78.49 78.49 78.49 +4.99% 7,454
2026-08-12 74.76 74.76 74.76 74.76 +5.00% 11,746
2026-08-11 71.20 71.20 71.20 71.20 +5.00% 7,984
2026-08-10 67.80 67.81 67.80 67.81 +4.99% 26,353
2026-08-07 61.52 64.59 61.00 64.59 +4.99% 23,879
2026-08-06 61.23 62.00 61.00 61.52 +0.47% 7,425
2026-08-05 62.18 62.30 60.61 61.23 -1.53% 4,740
2026-08-04 62.00 62.80 60.00 62.18 +0.71% 11,685
2026-08-03 60.74 62.30 59.50 61.74 +1.65% 41,581
2026-07-31 60.51 62.44 58.08 60.74 +0.68% 33,353
2026-07-30 62.70 62.70 60.33 60.33 -2.28% 13,201
2026-07-29 60.55 62.78 60.00 61.74 +2.27% 25,556
2026-07-28 62.05 62.50 60.06 60.37 -1.85% 6,329
2026-07-27 60.10 62.50 60.10 61.51 +0.02% 4,633
2026-07-24 62.26 62.43 59.15 61.50 -1.22% 9,045
2026-07-23 63.00 63.99 60.62 62.26 -0.84% 7,466
2026-07-22 63.20 63.20 61.79 62.79 -0.17% 7,433
2026-07-21 62.75 64.98 62.17 62.90 -1.73% 4,870
2026-07-20 63.44 64.88 62.00 64.01 +0.90% 8,448
2026-07-17 63.60 64.45 61.20 63.44 -0.25% 7,501
2026-07-16 63.67 64.70 62.60 63.60 -0.11% 4,167
2026-07-15 63.80 64.44 62.75 63.67 +0.43% 8,691
2026-07-14 63.50 64.50 61.51 63.40 -0.55% 11,512
2026-07-13 62.08 64.25 60.16 63.75 +2.69% 9,613
2026-07-10 62.99 63.69 60.17 62.08 -0.13% 15,706
2026-07-09 63.86 64.30 62.00 62.16 -2.66% 13,893
2026-07-08 65.39 65.39 61.15 63.86 -0.58% 16,447
2026-07-07 65.51 66.00 63.77 64.23 -1.95% 20,234
2026-07-06 64.00 65.80 64.00 65.51 +0.77% 8,743
2026-07-03 65.90 65.90 64.01 65.01 +0.31% 5,728
2026-07-02 65.00 66.00 64.50 64.81 +0.03% 6,100
2026-07-01 66.99 66.99 64.61 64.79 -0.32% 7,617
2026-06-30 66.67 69.00 64.80 65.00 -2.34% 25,665
2026-06-29 68.00 68.00 65.10 66.56 -2.12% 4,096
2026-06-25 68.04 68.04 66.36 68.00 -0.06% 8,652
2026-06-24 68.05 68.40 66.60 68.04 -0.09% 3,770
2026-06-23 68.50 68.50 66.20 68.10 +1.14% 17,303
2026-06-22 67.90 69.80 67.00 67.33 -0.84% 22,613
2026-06-19 68.95 70.35 66.16 67.90 -1.21% 6,766
2026-06-18 67.70 69.50 66.35 68.73 +3.15% 30,920
2026-06-17 66.20 67.00 66.00 66.63 +1.09% 33,238
2026-06-16 66.39 67.00 65.10 65.91 -1.63% 41,440
2026-06-15 68.00 70.95 64.60 67.00 -1.47% 124,188
2026-06-12 68.79 69.00 66.60 68.00 +1.45% 10,237
2026-06-11 69.99 71.79 66.50 67.03 -3.11% 16,417
2026-06-10 72.40 72.40 69.18 69.18 -5.00% 21,651
2026-06-09 73.94 73.95 70.25 72.82 -1.51% 6,644
2026-06-08 73.50 76.00 71.81 73.94 +1.08% 4,134
2026-06-05 74.56 75.95 72.00 73.15 -1.89% 8,789
2026-06-04 74.70 75.90 74.11 74.56 -0.03% 3,463
2026-06-03 79.00 79.00 73.01 74.58 -2.84% 6,831
2026-06-02 80.80 81.49 76.30 76.76 -4.42% 217,912
2026-06-01 77.44 81.30 76.00 80.31 +3.71% 222,308
2026-05-29 80.02 80.02 77.00 77.44 -3.22% 18,713
2026-05-27 79.00 81.90 78.00 80.02 +1.63% 12,967
2026-05-26 80.00 81.68 77.90 78.74 +1.08% 46,093
2026-05-25 76.88 78.00 76.00 77.90 +1.33% 22,188
2026-05-22 75.97 77.25 75.00 76.88 +1.20% 6,434
2026-05-21 77.90 77.90 75.00 75.97 -0.74% 8,349
2026-05-20 75.04 76.90 74.05 76.54 +2.00% 16,310
2026-05-19 75.41 76.95 73.00 75.04 -0.15% 30,652
2026-05-18 77.55 77.70 74.50 75.15 -3.09% 16,522

News from the last 15 days More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 15 Oct 2026. Latest filing is for the expected quarter (Sep 2026). Company: Valiant Laboratories Limited, ISIN INE0JWS01017.

Promoters and group
74.94%
0.00 pp vs Jun 2026
Foreign portfolio investors
0.07%
+0.07 pp vs Jun 2026
Domestic institutions
0.08%
+0.08 pp vs Jun 2026
Mutual funds
0.00%
0.00 pp vs Jun 2026
Public (all, Category B)
25.06%
0.00 pp vs Jun 2026
Resident individuals up to Rs 2 lakh
10.57%
+0.25 pp vs Jun 2026

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jun 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group74.94%74.94%0.00 pp00.00 ppNo material change.
Foreign portfolio investors0.00%0.07%+0.07 pp+35,323+0.05 ppNo material change.
Domestic institutions0.00%0.08%+0.08 pp+44,927-No material change.
Mutual funds0.00%0.00%0.00 pp0-No material change.
Public (all, Category B)25.06%25.06%0.00 pp-0.00 ppNo material change.
Resident individuals up to Rs 2 lakh10.32%10.57%+0.25 pp+139,271+0.62 ppReported small resident holders rose. A percentage change is not proof that retail investors bought or sold.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

Largest holders named in the Sep 2026 filing.

NameTypeShares% of companyLocked-in shares
Dhanvallabh Ventures LLPBodies Corporate2,54,37,50046.84% 28,98,115
Santosh Shantilal VoraIndividuals Or HUF40,73,9877.50% 28,98,115
Shantilal Shivji VoraIndividuals Or HUF40,73,9877.50% 28,98,115
Paresh Shashikant ShahIndividuals Or HUF40,67,6907.49% -
Kanchan Shantilal VoraIndividuals Or HUF20,18,3623.72% -
Chandrakant Vallabhaji GogriIndividuals Or HUF10,16,9221.87% -

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202674.94%0.00 pp25.06%0.00 pp15 Oct 2026
Jun 202674.94%0.00 pp25.06%0.00 pp17 Jul 2026
Mar 202674.94%0.00 pp25.06%0.00 pp15 Apr 2026
Dec 202574.94%0.00 pp25.06%0.00 pp16 Jan 2026
Sep 202574.94%0.00 pp25.06%0.00 pp15 Oct 2025
Aug 202574.94%0.00 pp25.06%0.00 pp12 Aug 2025
Jun 202574.94%0.00 pp25.06%0.00 pp15 Jul 2025
Mar 202574.94%0.00 pp25.06%0.00 pp18 Apr 2025NSE
Dec 202474.94%0.00 pp25.06%0.00 pp14 Jan 2025NSE
Sep 2024 revised74.94%0.00 pp25.06%0.00 pp17 Oct 2024NSE
Jun 2024 revised74.94%0.00 pp25.06%0.00 pp17 Jul 2024NSE
Mar 2024 revised74.94%0.00 pp25.06%0.00 pp11 Apr 2024NSE
Dec 202374.94%0.00 pp25.06%0.00 pp18 Jan 2024NSE
Oct 202374.94%0.00 pp25.06%0.00 pp10 Oct 2023NSE
Sep 2023 revised74.94%-25.06%-19 Oct 2023NSE
Shareholding details

Loading...

Events

Not checked yet

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.